Jacobs Solutions Deep Value Investment Research

What does the cost structure look like? 【Fact】In FY2025, revenue from continuing operations was USD 12.030 billion, direct contract costs were USD 9.045 billion, and selling, general and administrative expenses were USD 1.803 billion. On these rough measures, direct costs were about 75% of revenue, and SG&A was about 15% of revenue. This is a typical human-capital-driven and project-delivery-driven business. Capital expenditure is not high, but people, project execution, claims, and receivables management are critical.

Does it depend on a few customers, policies, or key people? 【Fact】The company disclosed that in FY2025, backlog related to the U.S. federal government was about USD 2.2 billion, accounting for 9.5% of total backlog. In FY2024, it was USD 2.4 billion, or 11.1%. This shows the federal government is an important customer group, but not an overwhelming single exposure. At the same time, the company does rely on public infrastructure spending, life sciences and semiconductor investment cycles, high-end professional talent, and a project execution culture. Bob Pragada has been CEO since 2023 and became chair in 2024. He has held roles inside the company for many years, which helps operating continuity to some extent.

Is this a business I can understand and would be willing to hold if trading stopped for five years? 【View】Yes, I can understand it. This is a business that uses professional talent and project delivery capabilities to provide higher-value solutions for complex infrastructure and advanced facilities. It is neither a consumer staples company nor platform software, but the logic is clear. 【View】If the market closed for five years, I would be willing to hold the business itself. At today's price, I would not necessarily be willing to buy a large position. These are two separate questions.

Business understandability score: 4.5/5.

Industry and Competitive Landscape

【Fact】Jacobs operates in the relatively higher-quality part of the broad professional engineering, consulting, design, and project management industry, rather than the weakest corner of traditional asset-heavy construction contracting. In the ENR 2026 Top 500 Design Firms ranking, Jacobs ranked No. 1, AECOM ranked No. 2, Tetra Tech ranked No. 3, and WSP ranked No. 4, showing that Jacobs is in the industry's top tier by scale and brand visibility. Jacobs ranked No. 2 in the 2025 ENR list, which indicates continuity in its leadership position.

【Fact】Long-term demand is generally stable and supported by multiple structural factors: aging infrastructure renewal, energy security, environmental remediation, urban resilience, life sciences capacity construction, and expansion of data centers and semiconductor facilities all drive demand. In its Q2 FY2026 announcement, the company explicitly emphasized that growth came from data centers, semiconductors, water, energy and power, and transportation. Its 2025 backlog growth also mainly came from water, environment, energy, cities, and advanced facilities.

【Fact】Still, this is not an industry immune to disruption. Technology may not directly replace Jacobs, but AI, digital design tools, and collaboration platforms will change delivery efficiency and bidding methods. At the same time, changes in budget priorities, government funding cadence, and customer capital spending cuts can quickly affect orders. In its 10-K and earnings releases, the company itself lists macroeconomics, government spending, tariffs, tax-law changes, geopolitics, and customer funding capacity as major uncertainties.

【View】Overall, I would define the industry as: "a leading company in a fairly good industry subsegment," rather than "an absolute monopoly in an excellent industry." It is more attractive than traditional low-bid EPC, but weaker than industries with strong network effects or powerful consumer brands. Industry attractiveness score: 3.5/5.

Moat

【View】Jacobs has a moat, but it is not bottomless. More precisely, its moat is a combination of scale, reputation, complex delivery capability, customer relationships, talent organization, and portfolio management ability, rather than a monopoly built on one single point. Below is the breakdown.

Moat Breakdown

The judgments above are based on the company's description of its business model and digital capabilities, ENR rankings, backlog and project portfolio changes, and its capital allocation record.

Is the Moat Widening, Stable, or Narrowing?

【Inference】I lean toward stable to slightly widening. There are three reasons. First, in recent years the company has continued moving its portfolio toward higher-value, lighter-asset, higher-margin consulting and advanced facilities, including taking a controlling stake in PA in 2021, spinning off CMS/C&I and combining it with Amentum in 2024, and acquiring the remaining PA stake in 2026. Second, the gross margin and operating margin mix of I&AF and PA is better than traditional engineering contracting. Third, the company's investments in data, digital, and AI capabilities can improve delivery efficiency and customer stickiness. On the other hand, it has not created an impossible-to-copy technology monopoly, so the moat will not widen very quickly.

Replication Difficulty, Inflation Pass-Through, and Counter-Cyclicality

【View】For competitors, replicating Jacobs' leading position is not something that can be done by spending one or two years of capital expenditure. It requires many years of project track record, customer relationships, talent networks, global delivery systems, and accumulated reputation. This is more of a "time barrier" than a "technology patent barrier."

【Inference】In an inflationary environment, Jacobs' pricing power is medium. Pricing for consulting, planning, and PM/CM services is more flexible than long-term fixed-price construction. But the company also undertakes some design-build and at-risk projects, so it is not completely free from cost pass-through pressure. In 2025, an adverse ruling on a joint venture project led to a reserve charge, which reminds us that project contracts can periodically consume profits.

【View】In an economic downturn, Jacobs would probably still maintain operating resilience, but it likely cannot ignore the cycle the way sticky software or daily necessities can. I prefer to view Jacobs as a good business, but not a counter-cyclical myth. Moat strength score: 3/5.

Management and Capital Allocation

Is Management Trustworthy?

【Fact】Bob Pragada has served as CEO since 2023 and became chair in 2024. He joined the company in 2006 and has long held key operating roles inside the organization, making him an internally developed successor. The company imposes strict stock trading restrictions on directors and executives, implemented a clawback policy compliant with SEC/NYSE rules from 2023, and has clear share ownership requirements for executives and directors. From a governance framework perspective, this is fairly standard and sound.

【Fact】But "sound governance" is not the same as "deep shareholder alignment." The 2026 proxy statement shows that CEO Bob Pragada held about 259,183 shares, while executives and directors together held about 569,989 shares, both below 1% of total shares outstanding. This means interest alignment exists, but is not strong. For a company with annual revenue above USD 10 billion, I would prefer to see higher direct share ownership.

Is Capital Allocation Rational?

【Fact】In terms of direction, capital allocation follows a clear theme: sell lower-quality assets and add consulting and higher-value capabilities. In 2019, the company sold the ECR business. In 2021, it acquired a 65% controlling stake in PA Consulting. In 2024, it spun off CMS/C&I and combined it with Amentum. In 2026, it acquired the remaining PA stake. This direction is consistent with the strategy of moving from traditional engineering toward higher-value solutions.

【Fact】The problem lies in "price and timing." In FY2025, the company repurchased 7,687,625 shares, including shares bought at an average price of USD 133.51 under the 2023 authorization and USD 131.05 under the 2025 authorization. In the first half of FY2026, it repurchased another 3,389,433 shares at an average price of USD 139.21. The latest share price was about USD 119.86. At a minimum, this shows that repurchases over the past 18 months were not made in a clearly undervalued range. They looked more like execution of a capital return policy than high-odds contrarian capital allocation. For conservative value investors, this is a negative.

【Fact】On M&A, the initial consideration for acquiring the remaining PA stake in 2026 was about GBP 1.21 billion, paid with cash and 2,043,537 newly issued Jacobs shares, with another GBP 75 million of deferred consideration to be paid in 2028. Management expects annualized cost synergies to reach more than USD 20 million within 24 months. Strategically, the deal makes sense because it turns PA from a majority-owned business into full ownership. Financially, however, it materially raises debt and integration risk, so whether it truly creates value still needs to be proven by ROIC and cash flow over the next 2–3 years.

【Fact】In compensation design, the company emphasizes pay-for-performance. Short-term bonuses are tied to Adjusted Operating Profit, Adjusted Net Revenue, and Adjusted EBITDA Margin. Long-term PSUs are tied to Adjusted EPS and ROIC. After 2025, a one-time share-price multiplier was also added. I like seeing ROIC included in long-term incentives. It suggests the board at least understands that growth is not the objective; capital efficiency matters.

【View】Overall assessment: management is credible, the strategic direction is broadly right, and incentive metrics are relatively healthy, but capital allocation price discipline is not yet reassuring enough. Management and capital allocation score: 3/5.

Financial Quality and Owner Earnings

Key Financial Overview

The table below prioritizes data from official 10-K/annual reports. One caveat matters: after the Amentum spin-off in 2024, the continuing-operations basis is not fully comparable with earlier years. Therefore, I treat 2022–2025 as a relatively comparable "continuing-operations sample." Operating cash flow and free cash flow include effects from divested businesses as described in the annual reports, so the trend matters more than mechanical year-by-year comparison.

The revenue, backlog, cash flow, and share-count figures above come from the 2024/2025 annual reports and the Q2 FY2026 10-Q/earnings announcement.

Growth, Margins, and Cash-Flow Quality

【Fact】Continuing-operations revenue grew from USD 9.783 billion in FY2022 to USD 12.030 billion in FY2025, cumulative growth of about 23% over three years. In FY2025, I&AF revenue grew 4.3% year over year and operating profit grew 13.2%. PA revenue grew 7.5% and operating profit grew 16.4%. This indicates that portfolio optimization is indeed pulling growth toward higher profit quality.

【Fact】By segment profit, PA is clearly the higher-quality business. In FY2025, PA operating profit was USD 278.5 million on revenue of USD 1.2656 billion, implying an operating margin of about 22%. I&AF was about 8.4%. This is exactly why the market is willing to accept the company's narrative of transforming toward consulting and solutions.

【Fact】But GAAP profit is not linear. In 2025, I&AF was affected by a reserve related to an adverse interim decision on a joint venture project. In Q2 FY2026, the PA transaction created substantial one-time charges, including transaction-related compensation costs, foreign-exchange forward losses, and accelerated vesting of compensation arrangements at certain subsidiaries. In other words, Jacobs' accounting profit is often affected by portfolio transactions and project-specific shocks, so surface EPS alone is not enough.

【Fact】On cash flow, FY2025 operating cash flow fell to USD 687 million. The company explicitly explained that this was mainly due to higher receivables usage and higher cash taxes. By March 27, 2026, receivables and contract assets had risen to USD 3.556 billion, up further from USD 2.989 billion at the end of FY2025. This shows that while the business is asset-light, it is not free of working-capital pressure. Project recognition, billing milestones, claims, and payment timing can make cash conversion volatile.

Balance Sheet, Leverage, and Survivability

【Fact】At the end of FY2025, the company had USD 1.235 billion in cash and USD 2.236 billion of net long-term debt. By March 27, 2026, cash had increased to USD 1.37 billion, but net long-term debt jumped to USD 4.084 billion, mainly due to refinancing for the remaining PA stake acquisition. By my calculation, net debt after the acquisition was roughly USD 2.7 billion. The company still had about USD 995 million of unused revolving credit capacity, so liquidity was not immediately alarming, but the balance sheet was clearly heavier than at the end of FY2025.

【Fact】Meanwhile, Jacobs' book assets include a large amount of M&A-created intangibles. At the end of FY2025, goodwill was USD 4.781 billion and net intangible assets were USD 718 million. Goodwill alone represented 42.5% of total assets. This means: First, the company's "asset value" is largely built on future earnings power rather than monetizable hard assets. Second, if future integration is poor or earnings decline, impairment risk cannot be ignored. Third, this company is better valued by earnings power than by liquidation value.

【Inference】On survivability, I think the answer is yes. Jacobs is not a company with heavy fixed assets, high inventory, high leverage, and fragile interest coverage. Cash reserves, credit capacity, and backlog visibility are all decent. The real risk is not "running out of money tomorrow." The risk is that post-acquisition ROIC fails to recover, cash conversion misses expectations, and the market still assigns a relatively high multiple, gradually eroding valuation tolerance.

Owner Earnings Analysis

My owner earnings framework: 【Assumption】Owner Earnings ≈ net income attributable to continuing operations + depreciation and amortization − stock-based compensation − maintenance capital expenditure − normalized working-capital usage. This measure is closer than "adjusted EPS" to the cash that long-term owners can take out.

Conservative estimate: 【Fact】In FY2025, depreciation and amortization totaled about USD 237.6 million, stock-based compensation was about USD 61 million, and capital expenditure was USD 79 million. Operating cash flow for the 2025 reporting period was USD 686.7 million, and simple free cash flow was about USD 607.5 million. The company also clearly stated that 2025 cash flow was dragged down by receivables and taxes.

【Inference】If I roughly treat FY2025 net income attributable to continuing operations as about USD 315 million (reverse-calculated from diluted EPS of USD 2.58 and diluted shares of 121.9 million; this is my calculation, not the company's original wording), add back depreciation and amortization of USD 238 million, subtract stock-based compensation of USD 61 million, then conservatively treat maintenance capital expenditure as USD 50–60 million and normalized working-capital consumption as USD 50–100 million, conservative Owner Earnings would be about USD 500–600 million. I use a midpoint of USD 550 million. This figure is broadly close to FY2025 simple FCF of USD 607 million, but it is much more conservative than "adjusted profit."

【Conclusion】 I have more confidence that Jacobs' true distributable cash-flow capacity is around USD 550 million annualized, with 10%–15% fluctuation, rather than the "perfect profit" after all transaction adjustments are excluded during optimistic market periods. At the current market capitalization of about USD 14.15 billion, that equals about 25–26x Owner Earnings. On an enterprise value basis, it is even higher. For a professional services company with a medium moat and project volatility, this is not cheap.

Valuation and Margin of Safety

Current Valuation Profile

【Fact】As of May 29, 2026, J's latest share price was about USD 119.86, with a market capitalization of about USD 14.153 billion and enterprise value of about USD 17.339 billion. StockAnalysis shows that on current metrics, the company trades at PE 34.93x, P/FCF 29.24x, EV/EBITDA 16.92x, and ROIC 9.53%. Using the company's FY2026 adjusted EPS guidance of USD 7.10–7.35, I estimate forward PE at about 16.3–16.9x. This data set tells me: the market is willing to price Jacobs as an improving, higher-quality engineering and consulting platform rather than an ordinary project company, but it has not given it a hyper-growth software premium.

Owner Earnings Discounting Method

I split valuation into three scenarios. All of the following are my estimates, not company guidance.

Conservative scenario 【Assumption】Starting Owner Earnings of USD 500–550 million, average annual growth of 3% over the next ten years, discount rate of 10%, and terminal growth of 2.5%. 【Inference】The corresponding intrinsic value is about USD 66–80 per share. This scenario assumes PA synergies are only average, cash conversion is unstable, and industry demand continues but without clear excess growth.

Base scenario 【Assumption】Starting Owner Earnings of USD 550–600 million, average annual growth of 4%–5% over the next ten years, discount rate of 9%, and terminal growth of 3%. 【Inference】The corresponding intrinsic value is about USD 86–102 per share. If part of the stronger profit improvement in FY2026 guidance is also included, fair value can move up to the USD 95–120 range. This is the range I think deserves the most attention.

Optimistic scenario 【Assumption】Starting Owner Earnings of USD 600–650 million, average annual growth of 5%–6% over the next ten years, discount rate of 8%–8.5%, and terminal growth of 3%–3.5%. 【Inference】The corresponding intrinsic value is about USD 111–155 per share. This scenario requires smooth full integration of PA, delivery of FY2029 targets, sustained demand from data centers, semiconductors, and life sciences, and no material deterioration in ROIC due to acquisitions.

Relative Valuation Method

Putting Jacobs alongside comparable companies makes the issue clearer.

This relative valuation set is not original wording from official financial statements. It consists of market ratios compiled by StockAnalysis/Fiscal.ai in late May 2026 and is suitable for horizontal comparison. Its meaning is direct: Jacobs' valuation is materially higher than AECOM and Tetra Tech, and higher than Parsons on most metrics, while its ROIC is not higher than AECOM or Tetra Tech. This means that if you demand a margin of safety through peer comparison, J is not advantaged.

Asset Value and Liquidation Value Method

【Fact】At the end of FY2025, Jacobs' shareholders' equity was about USD 3.641 billion, while goodwill was USD 4.781 billion and net intangible assets were USD 718 million. 【Inference】In other words, tangible net assets are negative, roughly USD -1.86 billion. This is not inherently bad, since many excellent asset-light companies look the same, but it shows that Jacobs does not have strong asset-value downside protection. The investment case must be built on continuing earnings power. If earnings power is impaired, book value provides little cushion.

Price Range Judgment

Conservative intrinsic value range: USD 70–90. Fair intrinsic value range: USD 95–120. Optimistic intrinsic value range: USD 130–155.

【View】At the current price of USD 119.86, Jacobs is roughly at the upper end of the fair value range. For conservative investors, it is close to or slightly above fair value. It only looks cheap under a fairly optimistic integration and growth scenario.

Ideal buy price range: USD 75–90. This is the zone that I believe can provide a 20%–30% margin of safety.

Acceptable holding price range: USD 95–125. If you already own the stock and believe in PA integration and the FY2026–FY2029 roadmap, the current price is more like "holdable, but not attractive enough to add."

Clearly overvalued price range: above USD 135. In this zone, the market is largely prepaying for the full benefits of PA synergies, margin improvement, and strong end-market demand.

Margin of Safety Judgment

【Conclusion】The margin of safety is insufficient. The most fragile valuation assumption is that the market assumes the company can smoothly turn FY2026 profit improvement into sustainable long-term cash flow and keep post-acquisition debt in a comfortable zone. If growth undershoots expectations, margins give back gains, or valuation multiples revert toward lower peer levels, buying today could easily become a "good company, average to expensive price" situation. For balanced but conservative long-term investors, I think waiting for a better price is the higher-odds choice.

Risks, Comparisons, and Investment Checklist

Key Risks and Strongest Bear Case

The most important risk is not short-term volatility, but permanent capital loss.

First is M&A and leverage risk. The full PA acquisition in 2026 pushed long-term debt up to USD 4.084 billion. Although the company still has liquidity, if synergies disappoint, ROIC decline would be very damaging to valuation.

Second is project and receivables risk. In 2025, the company recorded a reserve due to an adverse ruling on a joint venture project. By the end of March 2026, receivables and contract assets had reached USD 3.556 billion. This shows that individual projects, claims, acceptance milestones, and payment timing can amplify volatility in this business. A high-quality project company is not necessarily stable every year.

Third is overvaluation risk. Relative to AECOM, Tetra Tech, and Parsons, J's EV/EBITDA and P/FCF are not cheap. Meanwhile, the 2025–2026 average repurchase prices were clearly above the latest share price, weakening my confidence that management will restrain repurchases when the stock is expensive.

There is also business model disruption risk. This may not come directly from technology substitution itself. It may come from changes in customer budget logic: if the capital spending boom in data centers, semiconductors, and life sciences cools, or if government spending priorities shift, Jacobs' growth slope would be revised down materially. In its forward-looking statements, the company itself lists competition, capital spending cuts, government budgets, tax law, tariffs, and geopolitical risks.

The strongest bear case is: The reason Jacobs looks increasingly attractive may partly be the combined effect of "portfolio improvement + cyclical upswing + non-GAAP beautification." PA has indeed improved margins, but it has also increased liabilities. Profit quality in 2026 is also distorted by many "transaction-related adjustments." If revenue growth returns to the low to mid single digits over the next 2–3 years, cash flow does not improve in step, and valuation falls back toward levels more like AECOM/TTEK, today's return would be mediocre. I do not think this bear case is weak.

Facts that would overturn the investment judgment: If the following occur in the future, I would admit the original judgment was wrong and might even consider selling: First, after full PA consolidation, ROIC still fails to rise over 2–3 years and instead remains below about 8%; Second, backlog growth stalls, book-to-bill falls below 1, and deterioration continues for several quarters; Third, receivables and contract assets keep expanding materially while operating cash flow does not follow; Fourth, the net debt-to-earnings capacity ratio stays high for a long time, causing capital allocation to be constrained by debt; Fifth, the company continues large repurchases while clearly overvalued.

Comparison with Other Opportunities

Compared with the strongest industry peers. If choosing between peers today, I do not see Jacobs as clearly superior to AECOM or Tetra Tech. The latter two currently have higher ROIC and lower relative valuations. Jacobs' strengths are a more distinctive portfolio, higher-margin characteristics from PA, and a more "attractive" positioning around infrastructure and advanced manufacturing. But the market has already prepaid for part of these benefits in the price.

Compared with a broad index. If you simply want long-term exposure to high-quality U.S. assets, SPY offers stronger diversification and reinvestment capacity. The StockAnalysis page shows SPY's current PE at slightly above 28x. Jacobs' current PE is higher due to transaction costs, while forward PE has returned to 16–17x, but the company also carries meaningfully higher project risk, integration risk, and single-stock-specific risk. So the question becomes: Is Jacobs' excess return potential enough to compensate for these extra risks? Around the current price, my answer is: not obvious.

Compared with the risk-free rate. The U.S. Treasury 10-year constant maturity yield on May 29, 2026 was about 4.45%. By comparison, based on my conservative Owner Earnings estimate, Jacobs' current owner earnings yield is only in the mid single digits. Based on FY2026 adjusted EPS, forward earnings yield is about 6%. This is not unattractive, but it is not wide enough for me to ignore execution and valuation risks.

【View】If I could hold only 5 assets, today's Jacobs would not automatically qualify for the portfolio. The reason is not that it is not good enough. The reason is that the odds are not high enough. In a portfolio, it is more like a candidate worth tracking for the long term while waiting for price, rather than a must-buy heavy position today.

Investment Checklist

The table below gives my concluding judgments based on the facts, assumptions, and inferences above.

Final Investment Conclusion

Final rating: Watch.

One-sentence investment thesis Jacobs is a good-quality, strategically well-directed, high-order-visibility engineering and consulting platform, but buying at the current price is more like buying a "good company" than buying a "clearly undervalued asset."

Core bullish reasons The company has clearly shifted toward a higher-quality professional services and consulting mix, and PA has a better profit structure than traditional engineering. Order visibility is strong, with Q2 FY2026 backlog reaching USD 26.965 billion and TTM book-to-bill at 1.4x. End-market demand remains strong in advanced manufacturing, data centers, semiconductors, water, energy, and transportation. Management incentives include ROIC and EPS constraints, so the company is not purely driven by scale expansion. The business is asset-light, capital expenditure is lower than traditional contractors, and long-term Owner Earnings capability is decent.

Core bearish reasons Current valuation is not cheap, and P/FCF and EV/EBITDA are clearly higher than several peers. Debt has risen materially after the full PA acquisition, increasing near-term integration and cash-conversion risk. Receivables and contract assets are rising, so cash flow is not smoothly linear. Average repurchase prices were higher than the latest share price, suggesting average timing discipline in capital allocation. Book assets are dominated by goodwill and intangibles, with limited asset-value downside protection.

Key assumptions PA integration can deliver synergies in around 24 months; FY2026–FY2029 margin improvement is not one-off; high-growth end-market demand does not collapse sharply; net debt can move back to a more comfortable range over the next several years; ROIC at least stays in the mid to high single digits and gradually rises.

Fair buy price My more comfortable buy range is USD 75–90. If I must broaden it, USD 90–100 can begin to enter the "actionable research" zone. The basis is requiring at least a 20%–30% margin of safety against the base value range of USD 95–120.

Target holding period If I bought it, I would hold with a horizon of at least 5–10 years and keep validating through backlog, ROIC, cash conversion, and net leverage rather than trading quarterly volatility.

Expected annualized return Conservative scenario: -2% to 1%. Base scenario: 4% to 7%. Optimistic scenario: 8% to 11%. This is an estimate based on the intrinsic value ranges, dividend yield, and degree of fundamental delivery over the next 5–10 years. It is not a precise promise.

Maximum downside risk In the worst case, if PA synergies fail, the growth slope is revised down, ROIC improvement fails, and the market reprices Jacobs closer to AECOM/Tetra Tech, a 30%–45% permanent capital loss in the share price would not be exaggerated. The real risk is not short-term volatility. It is buying at a price that is not cheap, then later discovering the business was not quite as good as expected.

Tracking indicators The most important tracking indicators are: total backlog and book-to-bill; I&AF and PA margins; operating cash flow and free cash flow conversion; growth in receivables and contract assets; net debt and interest costs; PA synergy realization; repurchase prices and amounts; ROIC; delivery against FY2026–FY2029 guidance; project reserves and claims events.

Signals that would trigger reassessment Backlog declines for consecutive periods; book-to-bill remains below 1; receivables deteriorate without cash-flow improvement; net debt stays elevated; PA synergy targets are delayed or reduced; another large project reserve appears; management continues large repurchases at high prices.

Final recommendation If you are a long-term business owner, Jacobs deserves a high-priority watchlist position because its direction, end markets, and order quality are all good. But if you are a balanced but conservative investor, I would not abandon price discipline just because it is a "good company." The more rational action now is not to chase. It is to wait patiently for a buying point with a better margin of safety and continue validating two facts: whether PA can truly raise long-term ROIC, and whether cash flow can keep up with accounting profit.

Open Questions and Limitations

Two limitations should be stated plainly. First, after the Amentum spin-off in 2024, Jacobs' historical reporting basis has a break, so a strictly comparable continuing-operations sequence longer than 5 years is incomplete. In the report, I have tried to separate "comparable continuing-operations data" from "historical full-company context." Second, peer relative valuation multiples come from public data aggregation pages such as StockAnalysis/Fiscal.ai. They are suitable as horizontal valuation references, but cannot replace building a complete peer model company by company.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.